Moderna Inc
For the period ended Mar 31, 2025. Filed May 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 1, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
On March 13, 2025, Abbas Hussain, one of ourdirectors, adopted a trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) (the Hussain 10b5-1 Plan). The Hussain 10b5-1 Plan provides for the sale on June 11, 2025 of up to 313 shares of the Company’s common stock to satisfy tax obligations in connection with the vesting of equity awards. The Hussain 10b5-1 Plan expires on June 30, 2025, or upon the earlier completion of all authorized transactions under the Hussain 10b5-1 Plan.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.